<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02197858</url>
  </required_header>
  <id_info>
    <org_study_id>HMPR1</org_study_id>
    <nct_id>NCT02197858</nct_id>
  </id_info>
  <brief_title>Comparability of Invasive and Non-invasive Haemodynamic Monitoring</brief_title>
  <acronym>HMPR1</acronym>
  <official_title>Clinical Comparison of Hemodynamic Parameters Using Invasive Versus Non-invasive Continuous Blood-pressure Technology During a Total Intravenous Anaesthesia (TIVA).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-N端rnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Erlangen-N端rnberg Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      During general anesthesia the basic non-invasive monitoring of hemodynamic parameters (blood&#xD;
      pressure, O2-saturation, cardiogram) is crucial. It can be enhanced to so called &quot;extended&#xD;
      hemodynamic monitoring&quot; depending on the operation and patient. Frequently an invasive&#xD;
      arterial cannula is used to provide continuous information on the blood pressure. This&#xD;
      invasive method is very accurate and clinically established, but can be linked to adverse&#xD;
      effects e.g. reduction of the circulation flow distal of the canulla, haematoma, infection&#xD;
      etc. ccNexfin (Edwards Lifescience) is a finger cuff measuring the blood pressure in a&#xD;
      non-invasive manner. It thus offers beat-to-beat information even about the extended&#xD;
      hemodynamic parameters as cardiac output (CO), cardiac index (CI), stroke volume (SV), stroke&#xD;
      volume index (SVI) and stroke volume variation (SSV), if connected to the clinical platform&#xD;
      EV1000 (Edwards Lifescience).&#xD;
&#xD;
      Assuming that the two methods are equal we plan to measure extended hemodynamic parameters&#xD;
      before, during induction and during ongoing anesthesia both invasive and non-invasive. Data&#xD;
      will be recorded every 30sec.&#xD;
&#xD;
      Clinical evaluation of the ccNexfin technology in respect to extended hemodynamic parameters&#xD;
      is to our knowledge rare and further assessment in this field is needed to offer patients a&#xD;
      potentially equally reliable but less invasive monitoring. Furthermore the study should model&#xD;
      the effect of remifentanil, propofol or its combination on haemodynamics .&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mean arterial pressure</measure>
    <time_frame>during anesthesia induction</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiac output</measure>
    <time_frame>during anesthesia induction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke volume variation</measure>
    <time_frame>during anaesthesia induction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke volume</measure>
    <time_frame>during anesthesia induction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>during anaesthesia induction</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">40</enrollment>
  <condition>Anesthesia</condition>
  <condition>Anesthesia, Intravenous</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients that get an elective surgery under general anesthesia&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  elective surgery with the necessity of an arterial catheter&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient not consented&#xD;
&#xD;
          -  peripheral vascular disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Erlangen</city>
        <state>Bavaria</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <study_first_submitted>July 22, 2014</study_first_submitted>
  <study_first_submitted_qc>July 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2014</study_first_posted>
  <last_update_submitted>December 3, 2015</last_update_submitted>
  <last_update_submitted_qc>December 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Erlangen-N端rnberg Medical School</investigator_affiliation>
    <investigator_full_name>Tino M端nster</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>invasive arterial pressure</keyword>
  <keyword>extended hemodynamic monitoring</keyword>
  <keyword>propofol</keyword>
  <keyword>remifentanil</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

